BEACON PHARMACEUTICALS PLC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.10 BDT | -2.12% |
|
+17.73% | -45.27% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: June | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 4.65B | 5.59B | 7.12B | 8.02B | 8.51B | |||||
Total Assets | 4.87B | 7.18B | 8.54B | 10.82B | 14.64B | |||||
Interest Expense | -153M | -149M | -165M | -338M | -461M | |||||
Income Tax Expense | 45.7M | -196M | 335M | 358M | 169M | |||||
CAPEX | -244M | -314M | -313M | -1.72B | -1.81B | |||||
EBT | 163M | 185M | 1.2B | 1.29B | 679M | |||||
Gross Profit | 2.28B | 2.87B | 3.69B | 4.15B | 4.29B | |||||
D&A | 549M | 511M | 385M | 440M | 519M | |||||
Operating Income | 323M | 343M | 1.42B | 1.68B | 1B | |||||
Net Income | 118M | 381M | 863M | 935M | 510M |
Geographical Revenue Distribution History
| Fiscal Period: June | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Bangladesh | 4.41B | 5.59B | 7.12B | 8.02B | 8.51B | |||||
Export | 235M | - | - | - | - |
- Stock Market
- Equities
- BEACONPHAR Stock
- Financials Beacon Pharmaceuticals PLC
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition